Nov. 7, 2011
Dehaier Medical Systems Ltd.
(Nasdaq: DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in
, today announced that it will release financial results for the third quarter of fiscal 2011 ended
September 30, 2011
Monday, November 14, 2011
before the start of trading in
the United States
Company management will host a conference call for investors on
Monday, November 14, 2011
7:30 a.m. EST
. Interested parties may access the call by dialing (8610) 5137-7322 internationally, and entering account No.: 16833078#, passcode: 999999# approximately 10 minutes prior to the scheduled start time.
For those unable to participate, the call will be available as a live, listen-only webcast on the Company's website at
. Following the live broadcast, an archive will be available for one year.
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products in
, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (
), Welch Allyn (
), HEYER (
), Timesco (UK), eVent Medical (US) and JMS (
). Dehaier's technology is based on five patents and five software copyrights; additionally, we have three pending patents and six pending software copyrights, and proprietary technology. More information may be found at
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
SOURCE Dehaier Medical Systems Ltd.